Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 16.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 110,498 shares of the real estate investment trust's stock after acquiring an additional 15,753 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in Healthpeak Properties were worth $2,217,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in DOC. State Street Corp bought a new stake in Healthpeak Properties during the 3rd quarter worth about $1,093,576,000. Geode Capital Management LLC bought a new stake in Healthpeak Properties during the 3rd quarter worth about $403,898,000. Charles Schwab Investment Management Inc. bought a new stake in Healthpeak Properties during the 3rd quarter worth about $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Healthpeak Properties during the 3rd quarter worth about $175,697,000. Finally, Sumitomo Mitsui Trust Group Inc. bought a new stake in Healthpeak Properties during the 3rd quarter worth about $102,615,000. Institutional investors own 93.57% of the company's stock.
Analysts Set New Price Targets
DOC has been the topic of a number of research analyst reports. Wells Fargo & Company decreased their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating on the stock in a report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft upgraded shares of Healthpeak Properties from a "hold" rating to a "buy" rating and upped their target price for the company from $20.00 to $28.00 in a research report on Monday, October 21st. Mizuho cut their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a research report on Thursday, December 5th. Royal Bank of Canada upped their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an "outperform" rating in a research report on Monday, November 4th. Finally, Robert W. Baird cut their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $24.08.
Read Our Latest Analysis on Healthpeak Properties
Healthpeak Properties Stock Up 2.6 %
NYSE DOC traded up $0.52 during trading hours on Thursday, reaching $19.98. 5,152,628 shares of the company's stock were exchanged, compared to its average volume of 4,850,870. The company has a market capitalization of $13.97 billion, a price-to-earnings ratio of 57.07, a price-to-earnings-growth ratio of 2.18 and a beta of 1.15. Healthpeak Properties, Inc. has a one year low of $16.01 and a one year high of $23.26. The company's 50-day moving average is $20.43 and its two-hundred day moving average is $21.48. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.31 and a current ratio of 1.35.
Healthpeak Properties Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th will be paid a dividend of $0.305 per share. This is a boost from Healthpeak Properties's previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a dividend yield of 6.11%. The ex-dividend date is Friday, February 14th. Healthpeak Properties's dividend payout ratio (DPR) is currently 342.87%.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
